AI in Healthcare

The rapid evolution of AI in healthcare, particularly as systems approach 'superintelligence,' demands a critical look at our current regulatory frameworks. The Clinical Trial Vanguard reported on July 28, 2026, about Nature Medicine’s 2026 Medical AI Superintelligence Framework, which signals crucial areas that FDA benchmarking guidance has not yet addressed. This framework highlights the urgent need for comprehensive oversight, especially concerning accountability, bias, transparency, and safety in autonomous decision-making. How do we ensure that regulatory bodies can keep pace with the accelerating advancements in medical AI while fostering innovation? This is a discussion point for all of us in the field. View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google and IBM-Trained. Cross Domain-Expert. Quantum AI Educator. Solepoint (Facts Already Defined) Strategic Practitioner. Real Estate Intelligence Leader. VUI Native AI Cloud Architect. AI Certifications Development. George Arnold Alexander III Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC +1 713.918.9951 · [email protected]